Gene: SOAT1
Official Full Name: sterol O-acyltransferase 1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the acyltransferase family. It is located in the endoplasmic reticulum, and catalyzes the formation of fatty acid-cholesterol esters. This gene has been implicated in the formation of beta-amyloid and atherosclerotic plaques by controlling the equilibrium between free cholesterol and cytoplasmic cholesteryl esters. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35317 | SOAT1 Knockout cell line (HeLa) | Human | SOAT1 | 1:3~1:6 | Negative | Online Inquiry |
KO35318 | SOAT1 Knockout cell line (HCT 116) | Human | SOAT1 | 1:2~1:4 | Negative | Online Inquiry |
KO35319 | SOAT1 Knockout cell line (HEK293) | Human | SOAT1 | 1:3~1:6 | Negative | Online Inquiry |
KO35320 | SOAT1 Knockout cell line (A549) | Human | SOAT1 | 1:3~1:4 | Negative | Online Inquiry |
SOAT1 Gene Knockout Cell Lines are genetically engineered cell lines in which the SOAT1 gene, responsible for secretory granule membrane lipid homeostasis, has been inactivated. This knockout enhances researchers' capabilities to study the functional roles of SOAT1 in various biological processes, particularly those related to cholesterol metabolism and lipid storage.
The primary mechanism of action of these cell lines involves the disruption of SOAT1, which leads to alterations in cellular cholesterol esters and free cholesterol levels, allowing for detailed assessments of lipid accumulation and its implications in metabolic disorders. Researchers can utilize these knockout cell lines to investigate the underlying mechanisms of diseases such as atherosclerosis, obesity, and diabetes, facilitating the identification of potential therapeutic targets.
The scientific importance of SOAT1 Gene Knockout Cell Lines extends to both research and clinical applications. In research settings, they are invaluable tools for exploring lipid metabolism, cellular stress responses, and the interplay between lipids and inflammatory pathways. In clinical contexts, understanding SOAT1's role could guide the development of innovative treatments for cardiometabolic diseases and other lipid-related disorders.
What sets these knockout cell lines apart from conventional alternatives is their specificity and reliability. By precisely knocking out the SOAT1 gene, researchers gain a clearer understanding of its function without the confounding effects that often accompany pharmacological inhibitors. Moreover, these cell lines are easily translatable to in vivo models, allowing for comprehensive studies across various biological systems.
For researchers and clinicians looking to deepen their understanding of lipid functions and associated diseases, SOAT1 Gene Knockout Cell Lines offer unparalleled opportunities for discovery. The ability to manipulate lipid pathways with high precision provides significant advantages for both basic and applied research.
Our company specializes in the development of advanced genetic models, and we have extensive expertise in gene editing technologies tailored for the biomedical community. By choosing SOAT1 Gene Knockout Cell Lines, you equip your laboratory with a cutting-edge resource that paves the way for innovative research and potential clinical breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.